The Central Marine Fisheries Research Institute (CMFRI) has commercialised the patent-protected technologies of two seaweed-based nutraceutical products — one to boost anti-viral immunity and the other to combat high cholesterol or dyslipidemia. The products are expected to reach the market within six months from Pioneer Pharmaceuticals.
A communication from ICAR-CMFRI said A. Gopalakrishnan, Director of the institute, had signed a licence agreement with Joby George, managing partner, Pioneer Pharmaceuticals Limited, a wellness and pharmaceutical company based in Kochi, for commercial production and marketing of the products.
The nutraceuticals are a 100% natural blend of highly nutritious bioactive ingredients extracted with eco-friendly ‘green’ technology, Dr. Gopalakrishnan said.
